Alison Kiley
CIK 1341637 · last filed 2011-08-09
Alison Kiley is a corporate insider who has filed 7 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing shows the insider bought $120.7K of AEGR on Aug 9, 2011. Across all open-market trades the lifetime net is +$6.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $194.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$194.68M
2
7
$6.12M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Director | 2,690,251 | — | — | $6.12M | 4 | 2011-08-09 |
| PODD | Director | 1,192,453 | $163.26 | $194.68M | $0 | 3 | 2008-05-12 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-08-09 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Buy (P) | +9,700 | $120.7K | EDGAR |
| 2011-06-03 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-11-10 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Buy (P) | +315,789 | $3.00M | EDGAR |
| 2010-10-27 | Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | Mixed | +2,680,551 | $8.81M | EDGAR |
| 2008-05-12 | PODD | Grant (A) | — | $0 | EDGAR |
| 2007-11-13 | PODD | Sell (S) | −511,052 | $0 | EDGAR |
| 2007-05-18 | PODD | Conv (C) | +1,703,505 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.